Pharmacotherapy of Liver Fibrosis and Hepatitis: Recent Advances
A special issue of Pharmaceuticals (ISSN 1424-8247). This special issue belongs to the section "Pharmacology".
Deadline for manuscript submissions: 10 November 2024 | Viewed by 66
Special Issue Editor
Interests: viral hepatitis B; viral hepatitis C; steatosis; liver fibrosis; hepatocellular carcinoma
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
According to the World Health Organization, of the four most prevalent infectious diseases, the incidences of tuberculosis, malaria, and human immunodeficiency virus are declining (the former two since 1990; the third since 2005), and only hepatitis B and C (HBV and HCV, respectively) are continuing to rise in their incidence. These two viruses can cause severe liver fibrosis as well as hepatocellular carcinoma (HCC). More recently, steatotic liver disease (SLD) has also become a major cause of HCC with and without cirrhosis. There are major developments in the treatment of these diseases.
Prof. Dr. Ching-Lung Lai
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceuticals is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- treatment of HBV
- HCV
- SLD
- detection and prevention of liver fibrosis and HCC
